Novel inhibitors of RANKL-induced osteoclastogenesis: Design, synthesis, and biological evaluation of 6-(2,4-difluorophenyl)-3-phenyl-2H-benzo[e][1,3]oxazine-2,4(3H)-diones

Chia Chung Lee; Fei Lan Liu; Chun Liang Chen; Tsung Chih Chen; Feng Cheng Liu; Ahmed Atef Ahmed Ali; Deh Ming Chang; Hsu Shan Huang

doi:10.1016/j.bmc.2015.06.007

Novel inhibitors of RANKL-induced osteoclastogenesis: Design, synthesis, and biological evaluation of 6-(2,4-difluorophenyl)-3-phenyl-2H-benzo[e][1,3]oxazine-2,4(3H)-diones

Chia Chung Lee, Fei Lan Liu, Chun Liang Chen, Tsung Chih Chen, Feng Cheng Liu, Ahmed Atef Ahmed Ali, Deh Ming Chang, Hsu Shan Huang

Research output: Contribution to journal › Article › peer-review

21 Citations (Scopus)

Abstract

A series of novel 6-(2,4-difluorophenyl)-3-phenyl-2H-benzo[e][1,3]oxazine-2,4(3H)-dione derivatives were synthesized and evaluated for their inhibitory effects on osteoclast activities by using TRAP-staining assay. Among the tested compounds, 3d and 3h exhibited more potent osteoclast-inhibitory activities than the lead compound NDMC503 (a ring-fused structure of NDMC101), as reported in our previous study. Both 3d and 3h exhibited two-fold increase in activity compared to NDMC503. In addition, our biological results indicated that 3d and 3h could suppress RANKL-induced osteoclastogenesis-related marker genes, such as NFATc1, c-fos, TRAP, and cathepsin K. Notably, 3d could significantly attenuate the bone-resorbing activity of osteoclasts in the pit formation assay. Thus, this study might provide a new class of lead structures that warrant further development as potential anti-resorptive agents.

Original language	English
Pages (from-to)	4522-4532
Number of pages	11
Journal	Bioorganic and Medicinal Chemistry
Volume	23
Issue number	15
DOIs	https://doi.org/10.1016/j.bmc.2015.06.007
Publication status	Published - Jul 23 2015

Keywords

NDMC101
Osteoclastogenesis
Pit formation assay
RANKL
TRAP-staining assay

ASJC Scopus subject areas

Biochemistry
Molecular Medicine
Molecular Biology
Pharmaceutical Science
Drug Discovery
Clinical Biochemistry
Organic Chemistry

Access to Document

10.1016/j.bmc.2015.06.007

Cite this

Lee, C. C., Liu, F. L., Chen, C. L., Chen, T. C., Liu, F. C., Ahmed Ali, A. A., Chang, D. M., & Huang, H. S. (2015). Novel inhibitors of RANKL-induced osteoclastogenesis: Design, synthesis, and biological evaluation of 6-(2,4-difluorophenyl)-3-phenyl-2H-benzo[e][1,3]oxazine-2,4(3H)-diones. Bioorganic and Medicinal Chemistry, 23(15), 4522-4532. https://doi.org/10.1016/j.bmc.2015.06.007

Novel inhibitors of RANKL-induced osteoclastogenesis: Design, synthesis, and biological evaluation of 6-(2,4-difluorophenyl)-3-phenyl-2H-benzo[e][1,3]oxazine-2,4(3H)-diones. / Lee, Chia Chung; Liu, Fei Lan; Chen, Chun Liang et al.
In: Bioorganic and Medicinal Chemistry, Vol. 23, No. 15, 23.07.2015, p. 4522-4532.

Research output: Contribution to journal › Article › peer-review

Lee, CC, Liu, FL, Chen, CL, Chen, TC, Liu, FC, Ahmed Ali, AA, Chang, DM & Huang, HS 2015, 'Novel inhibitors of RANKL-induced osteoclastogenesis: Design, synthesis, and biological evaluation of 6-(2,4-difluorophenyl)-3-phenyl-2H-benzo[e][1,3]oxazine-2,4(3H)-diones', Bioorganic and Medicinal Chemistry, vol. 23, no. 15, pp. 4522-4532. https://doi.org/10.1016/j.bmc.2015.06.007

@article{0f057d11c6ba4f1e9a41944614292aa5,

title = "Novel inhibitors of RANKL-induced osteoclastogenesis: Design, synthesis, and biological evaluation of 6-(2,4-difluorophenyl)-3-phenyl-2H-benzo[e][1,3]oxazine-2,4(3H)-diones",

abstract = "A series of novel 6-(2,4-difluorophenyl)-3-phenyl-2H-benzo[e][1,3]oxazine-2,4(3H)-dione derivatives were synthesized and evaluated for their inhibitory effects on osteoclast activities by using TRAP-staining assay. Among the tested compounds, 3d and 3h exhibited more potent osteoclast-inhibitory activities than the lead compound NDMC503 (a ring-fused structure of NDMC101), as reported in our previous study. Both 3d and 3h exhibited two-fold increase in activity compared to NDMC503. In addition, our biological results indicated that 3d and 3h could suppress RANKL-induced osteoclastogenesis-related marker genes, such as NFATc1, c-fos, TRAP, and cathepsin K. Notably, 3d could significantly attenuate the bone-resorbing activity of osteoclasts in the pit formation assay. Thus, this study might provide a new class of lead structures that warrant further development as potential anti-resorptive agents.",

keywords = "NDMC101, Osteoclastogenesis, Pit formation assay, RANKL, TRAP-staining assay",

author = "Lee, {Chia Chung} and Liu, {Fei Lan} and Chen, {Chun Liang} and Chen, {Tsung Chih} and Liu, {Feng Cheng} and {Ahmed Ali}, {Ahmed Atef} and Chang, {Deh Ming} and Huang, {Hsu Shan}",

year = "2015",

month = jul,

day = "23",

doi = "10.1016/j.bmc.2015.06.007",

language = "English",

volume = "23",

pages = "4522--4532",

journal = "Bioorganic and Medicinal Chemistry",

issn = "0968-0896",

publisher = "Elsevier Ltd",

number = "15",

}

TY - JOUR

T1 - Novel inhibitors of RANKL-induced osteoclastogenesis

T2 - Design, synthesis, and biological evaluation of 6-(2,4-difluorophenyl)-3-phenyl-2H-benzo[e][1,3]oxazine-2,4(3H)-diones

AU - Lee, Chia Chung

AU - Liu, Fei Lan

AU - Chen, Chun Liang

AU - Chen, Tsung Chih

AU - Liu, Feng Cheng

AU - Ahmed Ali, Ahmed Atef

AU - Chang, Deh Ming

AU - Huang, Hsu Shan

PY - 2015/7/23

Y1 - 2015/7/23

N2 - A series of novel 6-(2,4-difluorophenyl)-3-phenyl-2H-benzo[e][1,3]oxazine-2,4(3H)-dione derivatives were synthesized and evaluated for their inhibitory effects on osteoclast activities by using TRAP-staining assay. Among the tested compounds, 3d and 3h exhibited more potent osteoclast-inhibitory activities than the lead compound NDMC503 (a ring-fused structure of NDMC101), as reported in our previous study. Both 3d and 3h exhibited two-fold increase in activity compared to NDMC503. In addition, our biological results indicated that 3d and 3h could suppress RANKL-induced osteoclastogenesis-related marker genes, such as NFATc1, c-fos, TRAP, and cathepsin K. Notably, 3d could significantly attenuate the bone-resorbing activity of osteoclasts in the pit formation assay. Thus, this study might provide a new class of lead structures that warrant further development as potential anti-resorptive agents.

AB - A series of novel 6-(2,4-difluorophenyl)-3-phenyl-2H-benzo[e][1,3]oxazine-2,4(3H)-dione derivatives were synthesized and evaluated for their inhibitory effects on osteoclast activities by using TRAP-staining assay. Among the tested compounds, 3d and 3h exhibited more potent osteoclast-inhibitory activities than the lead compound NDMC503 (a ring-fused structure of NDMC101), as reported in our previous study. Both 3d and 3h exhibited two-fold increase in activity compared to NDMC503. In addition, our biological results indicated that 3d and 3h could suppress RANKL-induced osteoclastogenesis-related marker genes, such as NFATc1, c-fos, TRAP, and cathepsin K. Notably, 3d could significantly attenuate the bone-resorbing activity of osteoclasts in the pit formation assay. Thus, this study might provide a new class of lead structures that warrant further development as potential anti-resorptive agents.

KW - NDMC101

KW - Osteoclastogenesis

KW - Pit formation assay

KW - RANKL

KW - TRAP-staining assay

UR - http://www.scopus.com/inward/record.url?scp=84937817628&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937817628&partnerID=8YFLogxK

U2 - 10.1016/j.bmc.2015.06.007

DO - 10.1016/j.bmc.2015.06.007

M3 - Article

C2 - 26081760

AN - SCOPUS:84937817628

SN - 0968-0896

VL - 23

SP - 4522

EP - 4532

JO - Bioorganic and Medicinal Chemistry

JF - Bioorganic and Medicinal Chemistry

IS - 15

ER -

Novel inhibitors of RANKL-induced osteoclastogenesis: Design, synthesis, and biological evaluation of 6-(2,4-difluorophenyl)-3-phenyl-2H-benzo[e][1,3]oxazine-2,4(3H)-diones

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this